Te‐Ling Lu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Cancer-related gene regulation
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 8
-
- Prostate Cancer Treatment and Research 21
- Co-authors
- Bo‐Ying Bao (46 shared papers)Shu‐Pin Huang (30 shared papers)Te‐Jung Lu (13 shared papers)Jian‐Lian Chen (8 shared papers)Ta-Yuan Chang (14 shared papers)Chao‐Yuan Huang (29 shared papers)Hong‐Zin Lee (11 shared papers)Chia‐Cheng Yu (20 shared papers)
- Journals
- International Journal of Molecular Sciences (7 papers)International Journal of Medical Sciences (4 papers)Cancer Genomics & Proteomics (4 papers)Cancer Medicine (3 papers)Microchimica Acta (3 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Te‐Ling Lu
87 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 248
- Molecular Biology 683
- Pulmonary and Respiratory Medicine 287
- Developmental Neuroscience 33
- Cell Biology 109
Countries citing papers authored by Te‐Ling Lu
This map shows the geographic impact of Te‐Ling Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐Ling Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐Ling Lu more than expected).
Fields of papers citing papers by Te‐Ling Lu
This network shows the impact of papers produced by Te‐Ling Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐Ling Lu. The network helps show where Te‐Ling Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Te‐Ling Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 69 | |
| 2 | 2009 | 66 | |
| 3 | 2010 | 64 | |
| 4 | 2009 | 63 | |
| 5 | 2011 | 47 | |
| 6 | 2016 | 45 | |
| 7 | 2010 | 43 | |
| 8 | 2011 | 39 | |
| 9 | 2014 | 38 | |
| 10 | 2019 | 34 | |
| 11 | 2015 | 33 | |
| 12 | 2010 | 32 | |
| 13 | 2008 | 32 | |
| 14 | 2015 | 28 | |
| 15 | 2010 | 27 | |
| 16 | Saikosaponin a protects TBI rats after controlled cortical impact and the underlying mechanism. | 2016 | 27 |
| 17 | 2019 | 25 | |
| 18 | 2010 | 23 | |
| 19 | 2011 | 22 | |
| 20 | 2010 | 22 |
About Te‐Ling Lu
Te‐Ling Lu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Biochemistry and Genetics, having authored 93 papers that have together received 1.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Cancer-related molecular mechanisms research (8 papers), Ion channel regulation and function (6 papers), Genetic Associations and Epidemiology (5 papers), Traumatic Brain Injury and Neurovascular Disturbances (5 papers), Natural product bioactivities and synthesis (5 papers), Cancer-related gene regulation (5 papers) and Luminescence and Fluorescent Materials (5 papers). The work is most often cited by research in Cancer Research (248 citations), Molecular Biology (683 citations), Pulmonary and Respiratory Medicine (287 citations), Developmental Neuroscience (33 citations) and Cell Biology (109 citations). Te‐Ling Lu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Bo‐Ying Bao, Shu‐Pin Huang, Te‐Jung Lu, Jian‐Lian Chen, Ta-Yuan Chang, Chao‐Yuan Huang, Hong‐Zin Lee, Chia‐Cheng Yu, Lumin Chen and Chi‐Jeng Hsieh. Their work appears in journals such as International Journal of Molecular Sciences, International Journal of Medical Sciences, Cancer Genomics & Proteomics, Cancer Medicine and Microchimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.